Navigation Links
Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
Date:11/7/2007

WALTHAM, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market, today announced results for its third quarter ended September 30, 2007.

The Company recorded revenue of $2.6 million for the third quarter, compared to revenue of $1.3 million for third quarter ended September 30, 2006, a 92% increase. Net loss for the quarter was $1.1 million, or $(0.04) per basic and diluted share compared to a net loss of $1.8 million, or $(0.07) per basic and diluted share for the same quarter last year.

The increase in revenue for the third quarter was attributable to the Company's Consumer Products segment which sells branded nutritional supplemental products to mass retail outlets. Interleukin reported $158,000 in revenue from its Genetic Testing segment, $1.8 million in revenue from its Consumer Products segment and $609,000 in revenue from its Research segment.

"During the quarter we refined our focus to better leverage our science and further establish Interleukin's leadership position in genetic testing and the personal wellness field", said Thomas Curran, interim Chief Executive Officer. "We have prioritized new product development programs in areas of significant opportunity such as gastric cancer and obesity. We continue to focus our efforts on our strategic relationship with Alticor to ensure strong marketing efforts and a positive consumer experience. As we look forward to the rollout of additional products in coming years we continue to explore new delivery channels and other potential strategic partners worldwide."


'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ss., Nov. 6 Myriant Technologies L...r and manufacturer of renewable bio-chemicals, Uh...logy provider Uhde GmbH, one of the world,s leadin...ced an alliance for the engineering, procurement &...inic Acid plants based on renewable feedstocks. T...
(Date:11/6/2009)...LEY, Calif., Nov. 6 Calbiotech, In...l Business Innovative Research (SBIR) Phase I cont...l command. Under terms of the agreement, Calbiotec...r the diagnosis of Dengue virus. ,, Dengue v... a major threat to military forces deployed to tro...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Pe... is set to take place on February 22-24, 2010 in P... conference we will highlight key issues in formin...re their experiences. , M...nda for Arrowhead’s 2010 Personalized Medic...
(Date:11/5/2009)..., Colo., Nov. 5 The endangered bla... western U.S. This rare carnivore feeds on prairi... plague and often entire population die-offs in to...FWS) has implemented a ferret breeding program and...their formerly native habitat. Unfortunately, pla...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
..., China, Nov. 7 /Xinhua-PRNewswire/ -- WuXi Pharma...nology and medical device research,and development...the United,States, announced today that it has sig...agreement with Pfizer., (Logo: http://www.newsco...harmaTech has enjoyed a close and cooperative rela...
...e cells known as eosinophils have a central role i...ssachusetts General Hospital, Boston, has develope...me eosinophil responses in the lungs and airways o...ntal allergic airway inflammation); they hope that...s the efficacy of treatments (both old and new) fo...
...M, N.C. Rods, cones, cubes and spheres move asid...meter, may hold the promise for new approaches to ...taminants. , While nanoparticles have been the ra... by Duke University bioengineers indicates that of...bove all the rest for certain applications. , Th...
Other Biology Technology:WuXi PharmaTech Signs New Collaboration Agreement With Pfizer 2Gold nanostar shape of the future 2Gold nanostar shape of the future 3
(Date:11/4/2009)...GE, N.Y., Oct. 21 What,s the cost ...ing accidental death resulting from prescription m...h good intentions, however, may be unaware that th...their teens from the ticking timebomb of prescript...r in premium-quality medical supplies, has formed ...
(Date:11/4/2009)...LSBAD, Calif., Nov. 4 GenVault Cor...am Brody, M.D., Ph.D., has joined its Board of Dir...Chair of the Salk Institute, is an acclaimed physi...ining the Salk Institute, Dr. Brody served as pres...mber of the National Academy of Engineering and th...
(Date:11/3/2009)...IDA, SPAINIn a research report published in a rece...lesias and Sim Alegre examined the effects of cove... color, fruit quality, canopy light distribution, ...ments were performed using Extenday and Solarmate ...in orchards of ,Mondial Gala, apples. The research...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Reflective film can boost profits for apple growers 2Cell transplantation and cardiac repair 50546 1Cell transplantation and cardiac repair 50546 2Cell transplantation and cardiac repair 50546 3Insurance Department Seeks Comment On Community Health Reinvestment Activities 50544 1Insurance Department Seeks Comment On Community Health Reinvestment Activities 50544 2Biocept Inc Announces Two New Director Appointments 12871 1Biocept Inc Announces Two New Director Appointments 12871 2
...MAA tiny electronic nose that MIT researchers have...uld be used to detect hazards including carbon mon... , Led by MIT professor Harry Tuller, the researc... onto a microchip, a process that could eventually... detectors. , Mass production would be an enormo...
...Y. Cornell University and the United Nations Univ...ntial solutions for the health, governance and sec... the UNU-Cornell Africa Series of moderated sympos...n to the public. , The focus of the Nov. 13 inaugu...interactions with health and nutrition. It will ta...
...Maryland November 9, 2007 Human Genome Sciences,...ion of Phase 2 clinical results demonstrating that...rovement in disease activity across multiple clini...lares over time, and was well tolerated through 2....of care in patients with active systemic lupus ery...
Other Biology News:MIT's 'electronic nose' could detect hazards 2MIT's 'electronic nose' could detect hazards 3First symposium of UN University-Cornell Africa Series to be held at UN 2HGS announces positive Phase 2 LymphoStat-B at ACR meeting 2HGS announces positive Phase 2 LymphoStat-B at ACR meeting 3HGS announces positive Phase 2 LymphoStat-B at ACR meeting 4
Neutrophil Chip-IHC from 3H Biomedical AB
NK Cell Chip-IHC from 3H Biomedical AB
UCB PDC Cell Chip-IHC from 3H Biomedical AB
Guanosine 5′-O-(2-Thiodiphosphate), Trilithium Salt from Calbiochem
Biology Products: